Vice President, Program Leadership (Launch Products)

Mirum Pharmaceuticals, Inc.; Foster City (CA); Hybrid; USD 350,000 - 600,000; Full time

Job summary

Mirum Pharmaceuticals is seeking a Vice President, Program Leadership (Launch Products) in Foster City to define and drive the global strategy for maximizing long-term value of a late-stage portfolio. The role leads a cross-functional team across U.S.

and international commercial, development, regulatory, medical affairs, and more, acting as the Program CEO for strategy and execution. The VP will oversee LIVMARLI, ATEBRIOZ, CHOLBAM, and CTEXLI, prioritizing opportunities to maximize patient

Qualifications

• 15+ years of experience in the biopharmaceutical industry, with significant experience in commercial strategy, marketing, new product planning, global commercialization, or related leadership roles; prior experience in rare disease and/or specialty pharmaceuticals preferred.
• Demonstrated success leading global product or lifecycle strategy for marketed and/or late-stage products, including responsibility for maximizing product value across indications, geographies, patient populations, and stages of the product lifecycle.
• Strong commercial foundation, with experience developing product strategy, positioning, forecasting, market development, launch planning, competitive strategy, and long‑range commercial plans.
• Global mindset and demonstrated ability to incorporate the needs and perspectives of U.S. and international markets into product strategy and investment decisions.
• Significant experience leading senior cross‑functional teams spanning Commercial, Development, Medical Affairs, Regulatory, Market Access, CMC/Technical Operations, Finance, and other functions, including leadership through influence without direct authority.
• Ability to operate as an enterprise product leader, integrating commercial, clinical, regulatory, medical, technical, and financial perspectives into a cohesive product strategy.
• Strong strategic and financial acumen, including experience developing business cases, evaluating investment alternatives, understanding product P&Ls and forecasts, and making resource‑allocation recommendations.
• Track record of making effective decisions in situations involving complexity, uncertainty, competing priorities, and cross‑functional trade‑offs.
• Strong understanding of the global biopharmaceutical commercialization environment, including the interplay among clinical evidence, regulatory strategy, market access, pricing/reimbursement, competitive dynamics, and commercial execution
• Demonstrated ability to influence and align senior executives and functional leaders, constructively challenge assumptions, resolve differences, and drive teams toward clear decisions and execution.
• Excellent executive communication skills, with the ability to synthesize complex information into clear strategic choices and recommendations for executive leadership and governance bodies.
• Strong orientation toward patient impact and value creation, with the ability to balance near‑term business performance with investments that maximize the long‑term potential of a product.
• Bachelor’s degree required; MBA or other advanced degree preferred.

Responsibilities

• Define and execute the integrated global lifecycle strategy for assigned products, establishing the long-term vision and value-maximization plan, taking into account risks, tradeoffs, and value
• Identify and prioritize opportunities across geographies, indications, patient segments, formulations, evidence generation, regulatory pathways, and other lifecycle initiatives.
• Continuously reassess product strategy based on emerging clinical data, competitive developments, market dynamics, regulatory changes, product performance, and IP considerations.
• Lead the cross-functional Program Team, including representatives from U.S. and International Commercial, Development, Regulatory, Medical Affairs, CMC/Technical Operations, Market Access, Finance, Legal, and other relevant functions.
• Working closely with regional commercial leaders, evaluate geographic expansion opportunities and commercialization models, including direct entry, distributors, partnerships, and licensing.
• Lead the evaluation of new indications, expanded patient populations, label enhancements, combination strategies, and other development opportunities
• Drive cross-functional decision-making, ensuring key trade-offs and internal resource constraints are identified, evaluated, and resolved.
• Working closely with Finance and other cross-functional leaders, rationalize, get endorsement, and manage the Program Team budget, as part of the annual long‑range planning exercise

Skills

Cross-functional leadership

Executive communication

Strategic thinking

Influence without authority

Financial acumen

Global mindset

Leadership through influence

Patient-focused value creation

Education

Bachelor's degree

MBA or advanced degree

Job description

Vice President, Program Leadership (Launch Products)

Foster City

MISSION

Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.

POSITION SUMMARY

The VP, Program Leadership (Launch Products)is accountable for defining and driving the global strategy to maximize the long-term value of Mirum’s late-stage products. The Program Leader leads a cross-functional team spanning U.S. and International Commercial, Development, Regulatory, Medical Affairs, CMC/Technical Operations, Market Access, Finance, and other functions, ensuring alignment around a single integrated product vision and strategy.

The VP, Program Leadership (Launch Products)will initially provide leadership across Mirum’s commercial-stage portfolio, including LIVMARLI, ATEBRIOZ, CHOLBAM, and CTEXLI, identifying and prioritizing opportunities to maximize patient impact and product value globally.

The Program Leader operates as “Program CEO,” leading product strategy and execution, influencing executive leadership, and bringing together cross-functional leaders around a shared vision

JOB FUNCTIONS/RESPONSIBILITIES

Global Product Strategy and Value Maximization for Commercial Portfolio

• Define and execute the integrated global lifecycle strategy for assigned products, establishing the long-term vision and value-maximization plan, taking into account risks, tradeoffs, and value
• Identify and prioritize opportunities across geographies, indications, patient segments, formulations, evidence generation, regulatory pathways, and other lifecycle initiatives.
• Continuously reassess product strategy based on emerging clinical data, competitive developments, market dynamics, regulatory changes, product performance, and IP considerations.
• Lead the cross-functional Program Team, including representatives from U.S. and International Commercial, Development, Regulatory, Medical Affairs, CMC/Technical Operations, Market Access, Finance, Legal, and other relevant functions.
• Working closely with regional commercial leaders, evaluate geographic expansion opportunities and commercialization models, including direct entry, distributors, partnerships, and licensing.
• Lead the evaluation of new indications, expanded patient populations, label enhancements, combination strategies, and other development opportunities
• Drive cross-functional decision-making, ensuring key trade-offs and internal resource constraints are identified, evaluated, and resolved.
• Working closely with Finance and other cross-functional leaders, rationalize, get endorsement, and manage the Program Team budget, as part of the annual long‑range planning exercise

Success Criteria

The successful Program Leader will:

• Lead through influence across senior cross-functional stakeholders and create accountability across organizational boundaries.
• Balance commercial opportunity with scientific, regulatory, operational, and financial considerations, making explicit strategic choices and trade-offs.
• Prioritize lifecycle opportunities and investments based on patient impact, strategic fit, value creation, probability of success, investment requirements, and organizational capacity.
• Develop and communicate business cases, investment recommendations, and strategic scenarios to executive leadership and governance committees to drive timely decisions and resource allocation.
• Translate complex information into clear recommendations and decisions.
• Maintain a global, long‑term perspective while driving near‑term execution
• Represent the program and Mirum externally, with thought leaders, prospective partners, and other stakeholders

QUALIFICATIONS

Education /Experience:

• 15+ years of experience in the biopharmaceutical industry, with significant experience in commercial strategy, marketing, new product planning, global commercialization, or related leadership roles; prior experience in rare disease and/or specialty pharmaceuticals preferred.
• Demonstrated success leading global product or lifecycle strategy for marketed and/or late-stage products, including responsibility for maximizing product value across indications, geographies, patient populations, and stages of the product lifecycle.
• Strong commercial foundation, with experience developing product strategy, positioning, forecasting, market development, launch planning, competitive strategy, and long‑range commercial plans.
• Global mindset and demonstrated ability to incorporate the needs and perspectives of U.S. and international markets into product strategy and investment decisions.
• Significant experience leading senior cross‑functional teams spanning Commercial, Development, Medical Affairs, Regulatory, Market Access, CMC/Technical Operations, Finance, and other functions, including leadership through influence without direct authority.
• Ability to operate as an enterprise product leader, integrating commercial, clinical, regulatory, medical, technical, and financial perspectives into a cohesive product strategy.
• Strong strategic and financial acumen, including experience developing business cases, evaluating investment alternatives, understanding product P&Ls and forecasts, and making resource‑allocation recommendations.
• Track record of making effective decisions in situations involving complexity, uncertainty, competing priorities, and cross‑functional trade‑offs.
• Strong understanding of the global biopharmaceutical commercialization environment, including the interplay among clinical evidence, regulatory strategy, market access, pricing/reimbursement, competitive dynamics, and commercial execution
• Demonstrated ability to influence and align senior executives and functional leaders, constructively challenge assumptions, resolve differences, and drive teams toward clear decisions and execution.
• Excellent executive communication skills, with the ability to synthesize complex information into clear strategic choices and recommendations for executive leadership and governance bodies.
• Strong orientation toward patient impact and value creation, with the ability to balance near‑term business performance with investments that maximize the long‑term potential of a product.
• Bachelor’s degree required; MBA or other advanced degree preferred.

#LI-HYBRID

Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.

Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self‑identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.

As set forth in Mirum Pharmaceuticals’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service‑connected disability.

A "recently separated veteran" means any veteran during the three‑year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.